Private equity firm TVM Capital Healthcare Partners has announced plans to invest $200m over the next four years to grow its healthcare companies across the Gulf Arab region and India, Reuters has reported.
In addition to its central activities, TVM oversees subsidiaries including the Canada-based TVM Capital Life Science, which closed a $201m fund from limited partners including pharmaceutical company Eli Lilly last month.
TVM has made four investments in the region since 2009 via a $120m fund which aims to provide specialised services in partnership with Western firms, and is set to shortly close the purchase of a majority stake in Egypt-based medical equipment company Ameco Medical Industries.
Helmut Schuhsle, TVM’s chief executive, said: “Our growth plan is to build these companies into strong entities in the UAE and expand into the other Gulf markets and beyond.”